Optimal Sample Size Calculation in Cost-Effectiveness Longitudinal Cluster Randomized Trials
Fuente:
arXiv
Guardado en:
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Preprint |
| Publicado: |
2026
|
| Materias: | |
| Acceso en línea: | |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| _version_ | 1866915875655778304 |
|---|---|
| author | Wang, Hao Liu, Jingxia Cameron, Drew B. Tong, Jiaqi Spiegelman, Donna Meeker, Daniella Li, Fan |
| author_facet | Wang, Hao Liu, Jingxia Cameron, Drew B. Tong, Jiaqi Spiegelman, Donna Meeker, Daniella Li, Fan |
| contents | Longitudinal cluster randomized trials (L-CRTs) are increasingly used to evaluate the cost-effectiveness of healthcare interventions across multiple assessment periods, yet design methods for powering these trials remain underdeveloped. Existing methods for cost-effectiveness analyses in cluster settings are limited to simple parallel-arm cluster randomized trials with a single follow-up assessment period. These methods cannot accommodate the complex correlation structures in L-CRTs conducted over multiple periods, which require differentiation between within-period and between-period correlations for both clinical and cost outcomes, as well as between-outcome correlations. Moreover, while substantial methodological advances have been made for the design of L-CRTs with univariate outcomes, none specifically address cost-effectiveness objectives where clinical and cost outcomes must be jointly modeled. We provide a design-stage framework for powering cost-effectiveness L-CRTs across three design variants: parallel-arm, crossover, and stepped wedge designs. We derive closed-form variance expressions for the generalized least squares estimator of the average incremental net monetary benefit under a bivariate linear mixed model. We propose a standardized ceiling ratio that adjusts willingness-to-pay for relative outcome variability to inform optimal design. We then develop local optimal designs that maximize statistical power under known correlation parameters and MaxiMin designs that ensure robust performance across parameter uncertainty for all three design variants. Through a real stepped wedge trial data example, we demonstrate the sample size calculation for testing intervention cost-effectiveness under local optimal and MaxiMin designs. |
| format | Preprint |
| id |
arxiv_https___arxiv_org_abs_2603_19051 |
| institution | arXiv |
| publishDate | 2026 |
| record_format | arxiv |
| spellingShingle | Optimal Sample Size Calculation in Cost-Effectiveness Longitudinal Cluster Randomized Trials Wang, Hao Liu, Jingxia Cameron, Drew B. Tong, Jiaqi Spiegelman, Donna Meeker, Daniella Li, Fan Methodology Longitudinal cluster randomized trials (L-CRTs) are increasingly used to evaluate the cost-effectiveness of healthcare interventions across multiple assessment periods, yet design methods for powering these trials remain underdeveloped. Existing methods for cost-effectiveness analyses in cluster settings are limited to simple parallel-arm cluster randomized trials with a single follow-up assessment period. These methods cannot accommodate the complex correlation structures in L-CRTs conducted over multiple periods, which require differentiation between within-period and between-period correlations for both clinical and cost outcomes, as well as between-outcome correlations. Moreover, while substantial methodological advances have been made for the design of L-CRTs with univariate outcomes, none specifically address cost-effectiveness objectives where clinical and cost outcomes must be jointly modeled. We provide a design-stage framework for powering cost-effectiveness L-CRTs across three design variants: parallel-arm, crossover, and stepped wedge designs. We derive closed-form variance expressions for the generalized least squares estimator of the average incremental net monetary benefit under a bivariate linear mixed model. We propose a standardized ceiling ratio that adjusts willingness-to-pay for relative outcome variability to inform optimal design. We then develop local optimal designs that maximize statistical power under known correlation parameters and MaxiMin designs that ensure robust performance across parameter uncertainty for all three design variants. Through a real stepped wedge trial data example, we demonstrate the sample size calculation for testing intervention cost-effectiveness under local optimal and MaxiMin designs. |
| title | Optimal Sample Size Calculation in Cost-Effectiveness Longitudinal Cluster Randomized Trials |
| topic | Methodology |
| url | https://arxiv.org/abs/2603.19051 |